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Abstract
Probiotics are increasingly used in aquaculture to control diseases and improve feed diges-
tion and pond water quality; however, little is known about the antimicrobial resistance prop-
erties of such probiotic bacteria and to what extent they may contribute to the development
of bacterial resistance in aquaculture ponds. Concerns have been raised that the declared
information on probiotic product labels are incorrect and information on bacterial composi-
tion are often missing. We therefore evaluated seven probiotics commonly used in Vietnam-
ese shrimp culture for their bacterial species content, phenotypic antimicrobial resistance
and associated transferable resistance genes. The bacterial species was established by
16S rRNA sequence analysis of 125 representative bacterial isolates. MIC testing was
done for a range of antimicrobials and whole genome sequencing of six multiple antimicro-
bial resistant Bacillus spp. used to identify resistance genes and genetic elements associ-
ated with horizontal gene transfer. Thirteen bacterial species declared on the probiotic
products could not be identified and 11 non-declared Bacillus spp. were identified. Although
our culture-based isolation and identification may have missed a few bacterial species pres-
ent in the tested products this would represent minor bias, but future studies may apply cul-
ture independent identification methods like pyro sequencing. Only 6/60 isolates were
resistant to more than four antimicrobials and whole genome sequencing showed that they
contained macrolide (ermD), tetracycline (tetL), phenicol (fexA) and trimethoprim (dfrD,
dfrG and dfrK) resistance genes, but not known structures associated with horizontal gene
transfer. Probiotic bacterial strains used in Vietnamese shrimp culture seem to contribute
with very limited types and numbers of resistance genes compared to the naturally occur-
ring bacterial species in aquaculture environments. Approval procedures of probiotic prod-
ucts must be strengthened through scientific-based efficacy trials and product labels should
allow identification of individual bacterial strains and inform the farmer on specific purpose,
dosage and correct application measures.
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Introduction
Aquaculture is the fastest growing animal protein production sector worldwide and Asia con-
tributes annually with about 90% of the global seafood production [1]. Shrimp production in
the Mekong Delta of Vietnam alone was 358,477 tons in 2012 accounting for 75% of total
shrimp production and 90% of the total area in Vietnam used for shrimp farming [2]. The
intensive culture and rapid expansion of shrimp farming in Vietnam and elsewhere have been
negatively affected by various diseases, e.g. White Spot Syndrome Virus (WSSV), Yellow Head
Virus (YHV), White Feces Syndrome (WFS) and Early Mortality Syndrome (EMS) [3] and
water quality problems [4]. In particular tiger shrimp (Penaeus monodon) are prone to such
diseases [5] and this has been the main driving factor for farmers to change from black tiger to
white leg shrimp (Litopenaeus vannamei).
A wide range of antimicrobials, disinfectants and other compounds (e.g. nutritional feed
supplements) are used to prevent and control shrimp diseases as wells as improving pond
water quality. Rico et al. [6] reported that 19% (n = 32) of intensive shrimp farms in Vietnam
used oxytetracycline, ciprofloxacin and/or enrofloxacin to treat mainly Early Mortality Syn-
drome (EMS)/Acute Hepatopancreatic Necrosis Syndrome (AHPNS). The popularity of probi-
otic usage in shrimp aquaculture has grown worldwide, mainly because farmers often
experience limited effect of antimicrobial treatment, but also because of continued problems
and reports of antimicrobial residue findings in exported shrimp. Probiotic bacterial strains are
anticipated to inhibit pathogens by colonization of the gut-intestinal environment and produc-
tion of compounds that have a biocidal effect on shrimp pathogens [7]. Furthermore, probiotic
bacteria incorporated into shrimp feed may enhance uptake of various nutrients and increase
yield [8]. The popularity of probiotic use is highlighted by a recent study where 91% of sur-
veyed shrimp farmers used probiotics [6]. Among these, 84% applied probiotic products
directly into the pond water to improve water quality and to reduce environmental stress
whereas 16% of farmer’s mixed probiotics with pelleted feed. Rico et al. [6] further reported
that Bacillus subtilis, B. licheniformis, B. thuringiensis and Lactobacillus acidophilus were the
main bacterial species included in probiotic products used in Vietnamese shrimp culture with
bacterial species composition and concentration normally listed on the product labels. How-
ever, aquaculture farmers are generally uncertain about the effect of the many different types of
marketed probiotics, e.g. those used as feed supplement, whereas a change in water colour after
application of probiotics is seen as a sign of improved water quality (Tran Minh Phu, unpub-
lished data).
In contrast to antimicrobials, it is generally believed that probiotics do not play a role in the
development of resistance among aquatic animal bacterial pathogens or the general aquatic
microflora. Resistance developed through antimicrobial selection pressure may spread by dif-
ferent mechanisms, e.g. horizontal gene transfer via plasmids and other genetic elements [9].
Probiotic bacterial strains used in livestock production have actually been found to contain tet-
racycline resistance genes [10]. Also, the presence and expression of resistance genes located
on plasmids and transposons in Lactobacillus spp. and Bacillus spp. used as probiotics in foods
have been reported [11, 12]. In recent guidelines provided by authorities approving the use of
antimicrobials it is clearly stated that the presence of antimicrobial resistance in probiotic bac-
terial strains are not allowed [13]. Furthermore, bacterial species composition and a measur-
able beneficial effect and the associated mechanism(s) accounting for such effects seem often
not documented for many marketed probiotic products, e.g. the documentation to have probi-
otic approved for use in aquaculture seem also to vary between countries.
With reference to the increasing use of probiotics in shrimp and other types of aquaculture,
the objective of this study was to determine the bacterial species composition in probiotic
Antimicrobial Resistance in Probiotic Bacterial Strains
PLOS ONE | DOI:10.1371/journal.pone.0132338 July 6, 2015 2 / 21
products commonly used in Vietnamese shrimp culture. Furthermore, the phenotypic antimi-
crobial susceptibility and genetic basis for antimicrobial resistance in the isolated probiotic
strains was determined to assess likelihood of possible transfer of antimicrobial resistance.
Materials and Methods
Probiotic Products
Seven probiotic products commonly used in Vietnamese shrimp culture were purchased from
aquaculture chemical shops in Soc Trang and Bac Lieu province in the Mekong Delta [14].
Detailed information about the products is shown in Table 1. No specific permission was
required by any authority to collect the probiotic products which were purchased from local
chemical shops. Three probiotics (I, III and IV) were marketed as feed supplements and four
products (II, V, VI and VII) for water treatment in shrimp ponds. Four probiotics were in pow-
der form (I, III, IV, VII) and three contained pellets (II, V, VI). Two probiotic products were
imported (III, VI) and distributed by Vietnamese companies while the remaining products
were produced and distributed by local companies. Information on product labels was evalu-
ated, e.g. description of contents and formula; information of bacterial genus and species and
their concentrations; expiry date, and instruction and health protective measures of use. After
purchase, probiotics were stored at room temperature similar to storage conditions in the
chemical shops and transported to the University of Copenhagen, Denmark for bacteriological
analysis. The products were analysed at least one year before the declared date of expiration.
Isolation of Bacterial Strains
Based on the product labels of the seven products the following bacterial species were declared:
Bacillus licheniformis, B. subtilis, B.megaterium, B. laterrosporus, B. amyloliquefaciens, B. thur-
ingiensis, B.mesentericus, B. circulans, B. azotoformans, B. pantothenticus, B. coagulans, Lacto-
bacillus acidophilus, Pediococcus acidilactici, L. helveticus, L. lactic, L. sporogenes, Nitrobacter
spp., Nitrosomonas spp., Alcaligenes denitrificans, and Pseudomonas denitrificans (Tables 1 and
2). The microbiological analysis done was qualitative to identify the bacterial species as the aim
was not to determine concentration of the individual probiotic strains. Tenfold dilutions were
prepared for each probiotic products in peptone water (0.1% wt/vol). The products in pellet
form were dissolved in peptone water (0.1% wt/vol) using a magnetic stirrer. For the isolation
of Bacillus spp., tenfold dilutions were spread on blood agar (CM 0055, Oxoid, Basingstoke,
Hampshire, England) directly and after a spore activating heat treatment at 85°C for 10 min.
Plates were incubated at 30°C for 24 ± 3 h. Pseudomonas denitrificans was also recovered on
blood agar following incubation at 30°C for 24 ± 3 h. Lactobacillus spp. and Pediococcus acidi-
lactici were isolated on blood agar, de Man Rogosa and Sharpe (MRS) agar (CM 0361, Oxoid),
and All Purpose Tween (APT) agar (1.10453.0500, Merck, Darmstadt, Germany) following
incubation at 30°C for 72 h in microaerophilic/anaerobic atmospheres. We did not aim to iso-
late Nitrobacter spp., Nitrosomonas spp. and Alcaligenes denitrificans as only one product
declared to contain these bacteria, but also because of the long incubation period (one to sev-
eral months for Nitrobacter) required for their isolation.
The colonies on blood agar were categorised into different types according to their colony
characteristics: color, opacity, surface and border structure, diameter size and haemolytic prop-
erty. Between three to five colonies of each morphology type were randomly selected and sub-
cultured on blood agar to obtain pure cultures. The isolates were characterised by the Gram
reaction using 3% (wt/vol) potassium hydroxide (Bie and Berntsen, Herlev, Denmark), motil-
ity, cytochrome oxidase test (NN-Dimethyl-p-phenylene-diamine dihydrochloride, Remel
Europe Ltd., Dartford, UK), and catalase test following the procedures described by Cowan
Antimicrobial Resistance in Probiotic Bacterial Strains
PLOS ONE | DOI:10.1371/journal.pone.0132338 July 6, 2015 3 / 21
T
ab
le
1.
In
fo
rm
at
io
n
ab
o
u
tt
h
e
se
ve
n
p
ro
b
io
tic
p
ro
d
u
ct
s
an
al
yz
ed
.
P
ro
d
u
ct
co
d
e
S
o
u
rc
e
o
ri
g
in
D
ec
la
re
d
co
n
te
n
t
C
o
n
ce
n
tr
at
io
n
s
(C
F
U
/k
g
)
T
ra
n
sl
at
io
n
o
f
d
ec
la
re
d
in
fo
rm
at
io
n
o
n
fu
n
ct
io
n
o
f
p
ro
d
u
ct
D
ec
la
re
d
d
o
se
an
d
ap
p
lic
at
io
n
P
ac
ka
g
e
w
ei
g
h
t
E
xp
ir
y
d
at
e
F
o
rm
L
o
t
n
u
m
b
er
I
V
ie
tn
am
B
ac
ill
us
su
bt
ili
s
1.
5
×
10
2
P
ro
vi
de
di
ge
st
iv
e
en
zy
m
es
an
d
us
ef
ul
ba
ct
er
ia
to
im
pr
ov
e
fe
ed
di
ge
st
ib
ili
ty
in
sh
rim
p;
im
pr
ov
e
th
e
ef
fi
ci
en
cy
of
fe
ed
us
e.
U
se
3-
5g
/1
kg
fe
ed
,a
pp
ly
on
ce
a
da
y.
1k
g
5/
3/
20
12
to
4/
3/
20
14
P
ow
de
r
T
P
81
00
91
P
ed
io
co
cc
us
ac
id
ila
ct
ic
i
1.
2
×
10
1
1
La
ct
ob
ac
ill
us
ac
id
op
hi
lu
s
2
×
10
1
0
S
ac
ch
ar
om
yc
es
ce
re
vi
si
ae
1.
2
×
10
1
1
P
hy
ta
se
62
00
0
U
I/k
g
A
m
yl
as
e
24
00
0
U
I/k
g
II
V
ie
tn
am
B
.s
ub
til
is
1
×
10
8
D
eg
ra
de
or
ga
ni
c
w
as
te
s
in
se
di
m
en
ts
;i
m
pr
ov
e
th
e
w
at
er
an
d
se
di
m
en
tq
ua
lit
y.
U
se
1k
g
fo
r
20
00
-3
00
0m
3
.S
pr
ea
d
in
to
po
nd
in
th
e
ea
rly
m
or
ni
ng
be
tw
ee
n
8–
9
am
.
1k
g
14
/0
9/
20
14
P
el
le
t
T
K
07
-1
3
B
.l
ic
he
ni
fo
rm
is
1
×
10
8
B
.m
eg
at
er
iu
m
1
×
10
8
III
U
S
A
B
.l
at
er
ro
sp
or
us
0.
5
×
10
7
P
ro
vi
de
di
ge
st
iv
e
en
zy
m
es
to
im
pr
ov
e
fe
ed
di
ge
st
ib
ili
ty
in
sh
rim
p;
pr
ev
en
ta
nd
tr
ea
tm
en
to
fw
hi
te
fe
ce
s/
st
oo
ld
is
ea
se
;i
nh
ib
it
gr
ow
th
of
E
.c
ol
i,
V
ib
rio
,A
er
om
on
as
;e
nh
an
ce
im
m
un
e
sy
st
em
;i
nc
re
as
e
su
rv
iv
al
ra
te
;r
ed
uc
e
st
re
ss
.
U
se
3g
/1
kg
fe
ed
,a
pp
ly
fo
ur
tim
es
a
da
y.
D
ilu
te
pr
od
uc
tw
ith
50
m
L
of
w
at
er
th
en
m
ix
it
w
ith
fe
ed
,l
ea
ve
fo
r
10
m
in
an
d
co
ve
r
by
bi
nd
er
(n
o
sq
ui
d
oi
lu
se
).
45
4g
3/
11
/
20
11
to
5/
11
/
10
13
P
ow
de
r
31
0-
20
10
/
D
V
B
.a
m
yl
ol
iq
ue
fa
ci
en
s
0.
5
×
10
7
B
.m
eg
at
er
iu
m
1.
8
×
10
7
B
.t
hu
rin
gi
en
si
s
0.
2
×
10
7
B
.m
es
en
te
ric
us
0.
8
×
10
7
IV
V
ie
tn
am
L.
ac
id
op
hi
lu
s
1
×
10
6
P
ro
vi
de
di
ge
st
iv
e
en
zy
m
es
to
im
pr
ov
e
fe
ed
di
ge
st
ib
ili
ty
in
sh
rim
p.
U
se
10
g/
1k
g
fe
ed
,a
pp
ly
on
ce
a
da
y.
D
ilu
te
pr
od
uc
tw
ith
a
lit
tle
of
w
at
er
th
en
m
ix
it
w
ith
fe
ed
,l
ea
ve
fo
r
15
m
in
an
d
bi
nd
w
ith
“G
lu
e
F
is
h”
pr
od
uc
t.
1k
g
13
/0
9/
20
14
P
ow
de
r
T
T
06
-3
5
L.
sp
or
og
en
es
1
×
10
6
B
.s
ub
til
is
1
×
10
6
A
m
yl
as
e
10
00
U
I/k
g
P
ro
te
as
e
50
0
U
I/k
g
V
V
ie
tn
am
B
.c
irc
ul
an
s
0.
5
×
10
6
D
eg
ra
de
or
ga
ni
c
w
as
te
in
sh
rim
p
po
nd
se
di
m
en
t;
ab
so
rb
to
xi
c
ga
s
N
H
3
,N
O
3
- ,
N
O
2
- ,
H
2
S
,C
H
4
;c
le
an
po
nd
bo
tto
m
;e
nh
an
ce
fe
ed
in
ta
ke
of
sh
rim
p.
U
se
90
0g
fo
r
10
,0
00
m
3
.S
pr
ea
d
in
to
po
nd
w
ith
ou
ta
ny
di
lu
tio
n
w
ith
w
at
er
;a
pp
ly
es
pe
ci
al
ly
in
di
rt
y
se
di
m
en
ta
re
as
of
th
e
po
nd
.A
pp
ly
on
ce
at
fi
ve
da
ys
in
te
rv
al
s
at
8–
10
am
.
90
0g
15
/4
/
20
11
to
15
/4
/
20
13
P
el
le
t
74
23
47
9
B
.a
zo
to
fo
rm
an
s
0.
2
×
10
6
B
.p
an
to
th
en
tic
us
0.
4
×
10
6
B
.l
ic
he
ni
fo
rm
is
1.
2
×
10
6
(C
on
tin
ue
d
)
Antimicrobial Resistance in Probiotic Bacterial Strains
PLOS ONE | DOI:10.1371/journal.pone.0132338 July 6, 2015 4 / 21
T
ab
le
1.
(C
on
tin
ue
d
)
P
ro
d
u
ct
co
d
e
S
o
u
rc
e
o
ri
g
in
D
ec
la
re
d
co
n
te
n
t
C
o
n
ce
n
tr
at
io
n
s
(C
F
U
/k
g
)
T
ra
n
sl
at
io
n
o
f
d
ec
la
re
d
in
fo
rm
at
io
n
o
n
fu
n
ct
io
n
o
f
p
ro
d
u
ct
D
ec
la
re
d
d
o
se
an
d
ap
p
lic
at
io
n
P
ac
ka
g
e
w
ei
g
h
t
E
xp
ir
y
d
at
e
F
o
rm
L
o
t
n
u
m
b
er
B
.t
hu
rin
gi
en
si
s
0.
6
×
10
6
B
.c
oa
gu
la
ns
0.
5
×
10
6
B
.l
at
er
ro
sp
or
us
0.
2
×
10
6
V
I
In
di
a
B
.s
ub
til
is
9
×
10
9
D
eg
ra
de
or
ga
ni
c
w
as
te
in
sh
rim
p
po
nd
se
di
m
en
ts
;i
m
pr
ov
e
w
at
er
an
d
se
di
m
en
tq
ua
lit
y.
A
ts
to
ck
in
g
de
ns
iti
es
<
20
sh
rim
p/
m
2
ap
pl
y
40
kg
/h
a
be
fo
re
st
oc
ki
ng
;
ap
pl
y
10
kg
/h
a
tw
ic
e
a
m
on
th
af
te
r
st
oc
ki
ng
;A
ts
to
ck
in
g
de
ns
iti
es
>
20
sh
rim
p/
m
2
ap
pl
y
50
kg
/h
a
be
fo
re
st
oc
ki
ng
;a
pp
ly
10
kg
/h
a
tw
ic
e
a
m
on
th
af
te
r
st
oc
ki
ng
th
en
15
kg
/h
a
an
d
20
kg
/h
a
fo
r
th
e
fo
llo
w
in
g
m
on
th
s.
S
pr
ea
d
in
to
po
nd
in
th
e
ea
rly
m
or
ni
ng
be
tw
ee
n
8–
10
am
.
5k
g
26
/8
/
20
11
to
15
/8
/
20
16
P
el
le
t
W
11
00
37
L.
he
lv
et
ic
us
8
×
10
9
L.
la
ct
ic
1
×
10
9
N
itr
os
om
on
as
sp
p.
6
×
10
7
N
itr
ob
ac
te
r
sp
p.
6
×
10
7
P
se
ud
om
on
as
de
ni
tr
ifi
ca
ns
6
×
10
7
A
lc
al
ig
en
es
de
ni
tr
ifi
ca
ns
6
×
10
7
B
.l
ic
he
ni
fo
rm
is
1
×
10
6
S
.c
er
ev
is
ia
e
5
×
10
5
S
iO
2
,M
gO
,P
2
O
5
,
F
eS
O
4
,C
uS
O
4
,
M
nS
O
4
,C
aO
,V
2
O
3
,
C
oS
O
4
33
0g
,1
00
g,
10
0g
,1
g,
0.
8g
,0
.6
g,
0.
45
g,
0.
4g
,0
.2
g
in
1k
g
V
II
V
ie
tn
am
B
.s
ub
til
is
1.
5
×
10
9
D
eg
ra
de
or
ga
ni
c
w
as
te
in
sh
rim
p
po
nd
se
di
m
en
ts
;i
m
pr
ov
e
w
at
er
an
d
se
di
m
en
tq
ua
lit
y;
ab
so
rb
to
xi
c
ga
se
s
lik
e
N
H
3
,H
2
S
;i
m
pr
ov
e
w
at
er
co
lo
r,
e.
g.
ch
an
ge
co
lo
r
fr
om
gr
ee
n
or
da
rk
re
d
to
a
go
od
w
at
er
co
lo
r;
in
cr
ea
se
w
at
er
ox
yg
en
le
ve
l.
U
se
22
7g
/5
00
0m
3
,a
pp
ly
on
ce
fo
r
7
da
ys
.I
nc
as
e
di
rt
y
w
at
er
po
nd
,a
pp
ly
22
7g
/3
20
0m
3
;g
re
en
or
da
rk
re
d
w
at
er
co
lo
r,
ap
pl
y
22
7g
/1
60
0m
3
;
cy
an
op
hy
ta
an
d
ha
rm
fu
la
lg
ae
,
ap
pl
y
22
7g
/1
60
0m
3
22
7g
4/
10
/
20
14
P
ow
de
r
S
J1
20
40
1
L.
ac
id
op
hi
lu
s
1.
6
×
10
7
S
.c
er
ev
is
ia
e
1.
3
×
10
7
A
sp
er
gi
llu
s
ni
ge
r
1.
1
×
10
7
do
i:1
0.
13
71
/jo
ur
na
l.p
on
e.
01
32
33
8.
t0
01
Antimicrobial Resistance in Probiotic Bacterial Strains
PLOS ONE | DOI:10.1371/journal.pone.0132338 July 6, 2015 5 / 21
Table 2. Bacterial species isolated from probiotic products after incubation on blood agar for 24 h at 30°C and subsequent identification by 16S
rRNA analysis and their susceptibility to antimicrobials.
Probiotic Bacterial species Bacterial species identified Antimicrobial
resistancei
(purpose of
use)
declared on label ID.
no.
Species Colony morphology (color,
surface, margin, size in mm)
Accession
no. (%) d
I B. subtilis 1 B. licheniformisg Opaque, smooth, fine, 3 FN666245b (100) CHL, CLI, ERY, PEN,
TET, SXT
(feed
supplement)
P. acidilactici 2 B. licheniformis Opaque, smooth, fine, 4 FN666245b (100) -h
L. acidophilus 3 B. subtilis Brown, rough, irregular, 2 AP012496b (100) CLI
4 B. amyloliquefaciens Dull, rough, irregular, 2 HQ407277 b (100)
5 B. subtilis ss inaquasorum Dull, rough, irregular, 2 EU138467a (100) -h
6 B. subtilis ss subtilis Clear, wrinkled, irregular, 2 KC179631bc (100)
55 B. amyloliquefaciens ss
plantarum
White, wrinkled, irregular, 3 CP000560a (100)
56 B. sonorensis Clear, rough, irregular, 3 AF302118a (100) -h
57 B. sonorensis Clear, rough, irregular, 4 AF302118a (100) -h
58 B. methylotrophicus Dull, rough, irregular, 3 EU194897a (100) AMP, CHL, ERY
59 B. subtilis ss subtilis Dull, rough, irregular, 3 ABQL01000001a
(100)
AMP, CHL
60 B. licheniformis Clear, rough, irregular, 3 AE017333a (100) CHL, CLI, PEN
61 B. cereusf Glistening, granular flat,
irregular, hemolysis, 2
AE017194b (100) -h
62 B. safensis Dull, rough, irregular, 2 AF234854a (100) CLI
63 B. sonorensis Dull, rough, irregular, 3 AF302118a (100) CHL, CLI, PEN
96 B. cereusf Glistening, granular-flat,
irregular, hemolysis, 6
AP007209b (99) -h
97 B. cereusf Glistening, granular-flat,
irregular, hemolysis, 5
AP007209b (99) -h
98 B. cereusf Glistening, granular-flat,
irregular, hemolysis, 5
AP007209b (99) AMP, PEN, TET
99 B. subtilis ss inaquosorum Dull, wrinkled, irregular, 3 EU138467a (100)
100 B. subtilis Dull, wrinkled, irregular, 4 JQ403532bc (100) -h
101 B. subtilis ss subtilis Dull, wrinkled, irregular, 3 ABQL01000001a
(100)
-h
102 B. subtilis Dull, wrinkled, irregular, 2 JQ308575b (100)
103 B. subtilis Dull, wrinkled, irregular, 2 GU826165b (100)
104 B. subtilis Dull, wrinkled, irregular, 4 GU826165b (100) -h
105 B. methylotrophicus Dull, rough, irregular, 2 EU194897a (100) -h
106 B. subtilis ss inaquosorum Dull, rough, irregular, 2 EU138467a (100) -h
107 B. subtilis Dull, rough, irregular, 3 GU826165b (100) -h
II B. subtilis 50 B. amyloliquefaciens ss
plantarum
Dull, rough, irregular, 6 CP000560a (100) PEN
(water
treatment)
B. licheniformis 51 B. amyloliquefaciens ss
plantarum
Dull, rough, irregular, 5 CP000560a (100) -h
B. megaterium 52 B. amyloliquefaciens ss
plantarum
Dull, rough, irregular, 4 CP000560a (100) -h
53 B. amyloliquefaciens ss
plantarum
Dull, rough, irregular, 3 CP000560a (100) -h
54 B. amyloliquefaciens ss
plantarum
White, wrinkled, irregular, 3 CP000560a (100) -h
III B. laterrosporus 7 B. amyloliquefaciens Opaque, rough, irregular, 2 KC250199b (100)
(Continued)
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Table 2. (Continued)
Probiotic Bacterial species Bacterial species identified Antimicrobial
resistancei
(purpose of
use)
declared on label ID.
no.
Species Colony morphology (color,
surface, margin, size in mm)
Accession
no. (%) d
(feed
supplement)
B. megaterium 8 B. amyloliquefaciens ss
plantarumg
Opaque, rough, irregular, 2 HE617159b (100) CHL, CLI, ERY, TET
B.
amyloliquefaciens
9 B. tequilensis Frost glass, rough, irregular, 4 HQ223107a (100)
B. thuringiensis 10 B. subtilis Frost glass, rough, irregular, 3 CP002468b (100)
B. mesentericus 11 B. tequilensisg Frost glass, rough, irregular, 3 KC172053bc (100) CHL, ERY, PEN, TET,
SXT
12 B. subtilis ss inaquosorum Frost glass, rough, irregular, 3 EU138467a (100) -h
13 B. safensis Dull, flat, irregular, 2 AF234854a (100) CLI
14 B. amyloliquefaciens ss
plantarum
Dull, flat, irregular, 2 CP000560a (100) -h
15 B. subtilis ss inaquosorum Dull, rough, irregular, 5 EU138467a (100)
16 B. subtilis Dull, rough, irregular, 5 CP002468b (100) -h
17 B. subtilis ss inaquosorum Dull, rough, irregular, 4 EU138467a (100) -h
18 B. subtilis ss inaquosorum Dull, rough, irregular, 4 EU138467a (100) -h
19 B. tequilensis Dull, rough, irregular, 3 JN641294bc (100)
20 B. amyloliquefaciens ss
plantarum
Dull, rough, irregular, 3 CP000560a (100) ERY
IV L. acidophilus 21 B. tequilensis Dull, flat, irregular, 2 DQ989210b (100) PEN
(feed
supplement)
L. sporogenes 22 B. subtilis Dull, rough, irregular, 4 AP012495b (99)
B. subtilis 23 B. amyloliquefaciens ss
plantarum
Dull, rough, irregular, 3 CP005660b (100)
24 B. subtilis ss subtilis Dull, rough, irregular, 3 JQ396173b (100)
25 B. stratosphericus Dull, flat, irregular, 1 AJ831841a (100) CLI
26 B. cereus ATCC 10987eg Glistening, granular flat,
irregular, hemolysis, 5
AE017194b (99) AMP, CHL, PEN, SXT
27 B. cereus ATCC 10987e Glistening, granular flat,
irregular, hemolysis, 4
AE017194b (99) -h
64 Kleb. pneumoniae ss
ozaenae
Shiny, convex, fine, 2 Y17654a (100) AMP
65 Kleb. pneumoniae ss
ozaenae
Shiny, convex, fine, 2 Y17654a (100) -h
66 B. megaterium Watery, convex, irregular, 2 D16273a (100) -h
67 Aerococcus urinaeequi White, Elevated, fine, 2 D87677a (100) AMP. CHL, CLI, ERY,
OXA, PEN,SXT
68 B. amyloliquefaciens ss
plantarum
Dull, rough, irregular, 5 CP000560a (100) -h
69 B. amyloliquefaciens ss
plantarum
Dull, rough, irregular, 5 CP000560a (100) -h
70 B. megaterium Dull, rough-flat, irregular, 3 D16273a (100) CLI
71 B. safensis Dull, rough-flat, irregular, 3 AF234854a (100) CLI
72 B. amyloliquefaciens ss
plantarum
Dull, rough-flat, irregular, 3 CP000560a (100) -h
73 B. subtilis ss subtilis Opaque, rough, irregular, 3 ABQL01000001a
(100)
CLI
74 B. amyloliquefaciens ss
plantarum
Opaque, rough, irregular, 3 CP000560a (100) -h
(Continued)
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Table 2. (Continued)
Probiotic Bacterial species Bacterial species identified Antimicrobial
resistancei
(purpose of
use)
declared on label ID.
no.
Species Colony morphology (color,
surface, margin, size in mm)
Accession
no. (%) d
75 B. methylotrophicus Opaque, rough, irregular, 3 EU194897a (100) CHL
76 B. cereus ATCC14578 Te Glistening, rough, irregular,
hemolysis, 3
AE017194b (99) -h
77 B. cereus ATCC14578 Te Glistening, rough, irregular,
hemolysis, 3
AE017194b (99) -h
108 Kleb. pneumoniae ss
pneumoniae
Creamy, convex, fine, 2 AB004753a (100) AMP
109 Kleb. pneumoniae Creamy, convex, fine, 2 AB641122b (99) AMP
110 Kleb. singaporensis Creamy, convex, fine, 2 AF250285a (99) AMP
111 B. cereus ATCC 14579e Glistening, flat, irregular,
hemolysis, 2
AE016877b (99) -h
112 B. cereus ATCC 14579e Glistening, flat, irregular,
hemolysis, 3
AE016877a (100) -h
113 Kleb. pneumoniae ss
pneumoniae
Creamy, convex, fine, 2 AB004753a (100) -h
V B. circulans 28 B. megaterium Dull, rough, irregular, 2 GU252120b (100) CLI
(water
treatment)
B. azotoformans 29 B. subtilis ss subtilis Dull, rough, irregular, 3 ABQL01000001a
(100)
B. pantothenticus 30 B. tequilensis Dull, rough, irregular, 3 HQ154527b (99)
B. licheniformis 31 B. subtilis ss subtilis Dull, smooth, fine, 4 ABQL01000001a
(100)
-h
B. thuringiensis 32 B. subtilis Dull, smooth, fine, 4 HQ336634b (100)
B. coagulans 33 B. licheniformis Clear, convex, fine, 1 AE017333a (100) -h
B. laterrosporus 34 B. licheniformis Clear, convex, fine, 1 AE017333a (100) -h
35 B. firmus Clear, convex, fine, 1 X60616a (100) CLI, ERY, PEN
36 B. amyloliquefaciens Clear, rough, irregular, 5 CP003838bc (99) CLI
37 B. licheniformis Clear, convex, fine, 3 AE017333a (100) CHL, CLI, ERY
38 B. licheniformis Clear, convex, fine, 3 AE017333a (100) -h
39 B. subtilis ss inaquosorum Dull, convex, fine, 3 EU138467a (100)
40 B. firmus Dull, convex, fine, 4 X60616ac (100) -h
41 B. licheniformis Clear, convex, fine, 1 AE017333a (100) -h
42 B. aeriusg Clear, convex, fine, 1 AJ831843a (100) CIP, CHL
VI B. subtilis 43 B. subtilis ss inaquosorum Dull, wrinkled, irregular, 3 EU138467a (100 CHL
(water
treatment)
L. helveticus 44 B. vallismortis Dull, wrinkled, irregular, 6 AB021198a (100)
L. lactic 45 B. safensis Dull, rough-flat, irregular, 3 AF234854a (100) CHL, CLI
Nitrobacter spp. 46 B. safensis Dull, rough-flat, irregular, 3 AF234854a (100) -h
Nitrosomonas spp. 78 B. amyloliquefaciens Dull, smooth, fine, 4 CP002927b (100)
A. denitrificans 79 B. safensis Dull, rough-flat, irregular, 2 AF234854a (100) -h
P. denitrificans 80 B. pumilus Dull, rough, irregular, 2 JX860616bc (100) CLI
S. cerevisiae 81 B. licheniformis Clear, rough, regular, 2 AE017333a (100) -h
B. licheniformis 82 B. subtilis ss inaquosorum Clear, rough, irregular, 4 EU138467a (99) -h
84 B. licheniformis Clear, rough, irregular, 2 AE017333a (100) CHL, CLI
114 B. amyloliquefaciens Opaque, rough, irregular, 4 CP002927b (100) -h
115 B. subtilis Opaque, rough, irregular, 4 JN054738b (100)
116 B. subtilis ss inaquosorum Opaque, rough, irregular, 4 EU138467a (100) -h
117 B. pumilus Dull, wrinkled, irregular, 3 HQ650161b (100) -h
(Continued)
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Table 2. (Continued)
Probiotic Bacterial species Bacterial species identified Antimicrobial
resistancei
(purpose of
use)
declared on label ID.
no.
Species Colony morphology (color,
surface, margin, size in mm)
Accession
no. (%) d
118 B. pumilus Dull, wrinkled, irregular, 3 FJ705814b (99) -h
119 B. pumilus Dull, wrinkled, irregular, 3 AB354235b (100) -h
120 B. amyloliquefaciens ss
plantarum
Dull, wrinkled, irregular, 4 CP000560a (100) CLI
VII B. subtilis 47 B. subtilis Frost glass, rough, irregular, 2 JX960641bc (99) -h
(water
treatment)
L. acidophilus 48 B. amyloliquefaciens Frost glass, rough, irregular, 5 CP002927b (100) TET
S. cerevisiae 49 B. licheniformis Opaque, rough, regular, 3 AE017333a (100) -h
A. niger 85 B. amyloliquefaciens Opaque, rough, irregular, 3 CP000560a (100) CLI, CHL
86 B. licheniformis Opaque, rough, irregular, 3 AE017333a (100) -h
87 B. sonorensis Clear, rough, irregular, 2 AF302118a (100) CLI, ERY
88 B. amyloliquefaciens ss
amyloliquefaciens
Dull, rough, fine, 3 FN597644a (100)
89 B. licheniformis Dull, rough, fine, 4 AE017333a (100) CHL, CLI, ERY, PEN
90 B. subtilis ss inaquosorum Frost glass, rough, irregular, 3 EU138467a (100) CHL, CLI
91 B. nealsoniig Frost glass, flat, irregular, 2 EU656111a (100) CHL, CIP, ERY, SXT
92 B. subtilis ss inaquosorum Brown, flat, irregular, 3 EU138467a (100) -h
93 B. cereus ATCC 10987e Glistening, rough, irregular,
hemolysis, 3
AE017194b (100) -h
94 B. cereus ATCC 10987e Glistening, rough, irregular,
hemolysis, 3
AE017194b (100) -h
95 B. cereus ATCC 10987e Glistening, rough, irregular,
hemolysis, 3
AE017194b (99) -h
121 B. subtilis ss inaquosorum Dull, rough, irregular, 2 EU138467a (100) -h
122 B. vallisomortis Dull, rough, irregular, 2 AB021198a (100)
123 B. subtilis ss inaquosorum Dull, rough, irregular, 4 EU138467a (100) -h
124 B. cereus ATCC 10987e Glistening, rough, irregular,
hemolysis, 4
AE017194b (99) PEN
125 B. cereus ATCC 14579e Glistening, rough, irregular,
hemolysis, 3
AF090330b (99) -h
126 B. cereus ATCC 14579e Glistening, rough, irregular,
hemolysis, 3
AF090330b (99) -h
a Accession number for the Ez-Taxon database.
b Accession number for the GenBank database.
c Unpublished reference.
d Nucleotide similarity in percent.
e Bacillus cereus identified by gyrB sequencing analysis.
f Bacillus cereus identified by MALDI-TOF method.
g Strains characterized by whole genome sequencing.
-h Not tested.
i CLI, clindamycin; CIP, ciprofloxacin; CHL, chloramphenicol; ERY, erythromycin; PEN, penicillin; TET, tetracycline; SXT, trimethoprim/sulfamethoxazole;
AMP, ampicillin; GEN, gentamicin; OXA, oxacillin.
doi:10.1371/journal.pone.0132338.t002
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[15]. Loeffler’s polychrome methylene blue stain (McFadyen’s reaction) was used for spore
staining and the presence of spores was also studied using phase contrast microscopy. All
strains were cultured in Brain Heart Infusion broth (CM 1135, Oxoid) and stored at -80°C
with 30% (vol/vol) glycerol until further characterisation.
Bacterial Identification by 16S rRNA Sequence Analysis
A total of 94 bacterial isolates cultured on blood agar incubated for 24 ± 3 h at 30°C in ambient
atmospheric conditions and 31 isolates cultured on blood agar incubated at 30°C in anaerobic
conditions for 72 h, were selected as representatives of the different colony morphology types
(three to five isolates selected for each colony morphology type) seen after culture of the probi-
otic products. Identification of the presumptive Bacillus, Klebsiella and Aerococcus isolates
were confirmed by 16S rRNA sequence analysis. Total genomic DNA was extracted using the
DNeasy Blood & Tissue kit following the manufacturer’s protocol for Gram-positive and
Gram-negative bacteria (Qiagen, Hilden, Germany). The universal primer sets described by
Weisberg et al. [16] were employed for the sequencing of the 16S rRNA genes (Table 3).
Sequencing of the PCR amplicons was done by Macrogen, Inc (Seoul, Korea). The 16S rRNA
sequence data were compared with available sequence data in the GenBank and EZ-taxon data-
bases using the BLAST algorithm [17].
Discrimination of Bacillus cereus and B. thuringiensis
Bacillus cereus and B. thuringiensis are highly polyphyletic [18] and have similar genotypic and
phenotypic properties [19]. PCR of the gyrase B (gyrB) gene [20] and subsequent sequencing
was used to differentiate the two species (Table 2) [21, 22]. PCR amplification was performed
for 12 isolates under the following conditions: initial denaturation at 94°C for 3 min for 1 cycle,
35 cycles consisting of denaturation at 94°C for 45 sec, annealing at 63°C for 1 min and elonga-
tion at 72°C for 1 min, and a final extension at 72°C for 7 min [22]. B. cereus ATCC 11778 and
B. thuringiensis CCUG 7429T were used as positive controls. Sequencing of the PCR amplicons
was done by Macrogen, Inc, South Korea and data were compared with available gyrB gene
sequence data in the GenBank database using BLAST algorithm. Similarity of B. cereus and B.
thuringiensis were determined by pair wise comparison using ‘water’ available as EMBOSS pro-
gram on the EBI server (http://www.ebi.ac.uk/Tools/psa/emboss_water/nucleotide.html).
Table 3. Oligonucleotide primers used for 16S rRNA analysis and detection of the gyrB gene.
Species Primer Sequence (5´-3´) Target gene
Bacillus, Lactobacillus 8-27F AGA GTT TGA TCC TGG CTC AG 16S rRNA
Bacillus, Lactobacillus 1390–1408 R TGA CGG GCG GTG TGT ACA A 16S rRNA
Bacillus, Lactobacillus 786F GAT TAG ATA CCC TGG TAG 16S rRNA
Bacillus, Lactobacillus 786R CTA CCA GGG ATAT CTA ATC 16S rRNA
Bacillus, Lactobacillus 344R ACT GCT GCC TCC CGT 16S rRNA
Bacillus, Lactobacillus 344F ACG GGA GGC AGC AGT 16S rRNA
Bacillus, Lactobacillus 785 805 F GGA TTA GAT ACC CNG GTA GTC 16S rRNA
Bacillus, Lactobacillus 785 805R GAC TAC CNG GGT ATC TAA TCC 16S rRNA
Bacillus, Lactobacillus 37F GGC TCA GRW YGA ACG C 16S rRNA
Bacillus cereus BCJH-F TCATGAAGAGCCTGTGTACG gyrB
Bacillus cereus BCJH-1R CGACGTGTCAATTCACGCGC gyrB
Bacillus thuringiensis BTJH-1F GCTTACCAGGGAAATTGGCAG gyrB
Bacillus thuringiensis BTJH-R ATCAACGTCGGCGTCGG gyrB
doi:10.1371/journal.pone.0132338.t003
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Because of incomplete sequence data obtained for four isolates the identity of these isolates
were confirmed by phenotypic characteristics established using Matrix-assisted laser desorp-
tion/ionization-time of flight (MALDI-TOF, Biomerieux, Germany) [23]. In brief, the isolates
were identified by using an AXIMA Assurance (Shimadzu-Biotech) MALDI-TOF mass spec-
trometer machine (Shimadzu-Biotech, Kyoto, Japan). The isolates were prepared and analysed
according to the instructions of the manufacturer. Only profiles that passed the auto-quality
control with the Launchpad software (version 2.9) (Shimadzu-Biotech, Kyoto, Japan) were
used for spectrum accumulation. Escherichia coli ATCC 8739 was used as a calibrator and
internal identification control in each series of measurements. Raw spectra were automatically
processed with the Launchpad software and resulting peak lists were transferred to and ana-
lyzed with the SARAMIS software [23]. Comparison of sample spectra to SuperSpectra in the
SARAMIS database (version 4.09) was considered significant when a confidence value for a
match was at least 75%. All identification results with confidence values of at least 80% were
considered as reliable when no conflicts were indicated, i.e., when all significant matches gave
exactly the same species or genus, respectively. In case of no significant matches to SuperSpec-
tra, the sample spectra was compared to all reference spectra in the database and all spectra giv-
ing matches exceeding the minimum similarity criteria were shown for further manual
evaluation.
Phylogenetic Tree Analysis of Bacillus spp.
The regions of the multiple alignment that included the 5' (5´-AGA GTT TGA TCC TGG CTC
AG-3´) and 3' end 1390–1408 (TTGTACACACCGCCCGTCA) sequencing primers were
trimmed away and strains with identical sequences were only represented once in the phyloge-
netic analysis. Multiple alignments and neighbour joining phylogenetic analysis including cal-
culation of bootstrap support were done by ClustalX2 [24] and MEGA5 [25] was used for
graphical representation of trees. Sequences of less than 1 kb in length were excluded from the
multiple alignment and phylogenetic analysis and they were only analysed by Eztaxon-e com-
parison to sequences of type strains. Species identification of 16S rRNA sequences was based
on comparisons to similarity with type strains of species as provided in Eztaxon-e [26] using a
threshold of 99%. This will give an error of 5% in the identification [27].
Antimicrobial Susceptibility Testing
Antimicrobial susceptibility was determined for 65 strains selected among a total of 125 strains
identified. The strains were selected based on the criteria that the specimen selected showing
the highest nucleotide similarity percentage as compared with the Ez-taxon database and one
representative strain from each bacterial species identified in a particular product should be
represented. The strains selected included 60 Bacillus spp., one Aerococcus spp. and four Klebsi-
ella spp. strains. No Lactobacillus, Pseudomonas, and Pediococcus were isolated. Antimicrobial
susceptibility testing by broth microdilution was done using Sensititre GPALL1F and GN3F
panels (Trek Diagnostics System, East Grinstead, UK) according to guidelines from the Clinical
and Laboratory Standards Institute (CLSI) [28]. The GPALL1F (Gram-positive) panel included
β-lactams [ampicillin (AMP), penicillin (PEN) and oxacillin (OXA) with 2% NaCl] and non-β-
lactam antimicrobials [chloramphenicol (CHL), daptomycin (DAP), gentamycin (GEN), line-
zolid (LZD), rifampicin (RIF), tetracycline (TET), erythromycin (ERY), trimethoprim/sulfa-
methoxazole (SXT), quinupristin/dalfopristin (Q-D), vancomycin (VAN), levofloxacin (LVX),
tigeccycline (TGC), moxifloxacin (MXF), clindamycin (CLI), streptomycin (STR), ciprofloxa-
cin (CIP), and nitrofurantoin (NIT)]. While the GN3F (Gram-negative) panel included β-lac-
tams [ampicillin (AMP), ampicillin/sulbactam (SAM), aztreonam (ATM); cefazolin (CFZ),
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cefepime (FEP), meropenem (MEM), ertapenem (ETP), cefuroxime (CXM), cefoxitin (FOX),
cefpodoxime (CPD), ceftazidime (CAZ), ceftriaxone (CRO), cephalothin (CEF) and ticarcillin/
clavulanic acid (TIM) constant 2] and non- β-lactam antimicrobials [amikacin (AMK), genta-
micin (GEN), ciprofloxacin (CIP), pipercillin/tazobactam (TZP) constant 4, tobramycin, tigec-
cycline (TGC) trimethoprim/sulfamethoxazole (SXT) and tetracycline (TET)]. Following 48 h
incubation at 30°C [29], the plates were read using Sensititre Vizion System (Trek Diagnostics
System) and MIC values were interpreted according to CLSI breakpoints for Staphylococcus
spp. [29] and Escherichia coli [28]. As there are no guidelines breakpoints for Bacillus spp. in
CLSI guideline and Bacillus spp. are mainly fastidious Gram-positive bacteria like Staphylococ-
cus spp. therefore the breakpoints of Staphylococcus spp. were used as criteria for interpreta-
tion. The breakpoints of E. coli are recommended and used for other Enterobacteriaceae such
Klebsiella species [28].
Whole Genome Sequence Analysis to Identify Antimicrobial Resistance
Genes
As Bacillus spp. were by far the most commonly declared and isolated bacterial species
(Table 2), six representative isolates including B. licheniformis, B. amyloliquefaciens, B. tequi-
lensis, B. cereus, B. aerius, and B. nealsonii were selected for whole genome sequencing to deter-
mine antimicrobial resistance genes. The isolates were selected based on their multiple
antimicrobial resistance patterns mainly to antimicrobials used therapeutically in humans e.g.
ciprofloxacin, tetracycline, sulfamethoxazole/trimethoprim, erythromycin and clindamycin.
Paired-end Illumina sequencing of the strains was carried out on an Illumina Miseq, following
standard Illumina protocols (Illumina, Inc., USA). Available genes in the ResFinder database
[30] were BLASTed against the assembled genome, and the best-matching genes were counted
as output [30]. The contigs with identified resistance genes were blasted against the NCBI data-
base and the regions surrounding the resistance genes examined for potential genes associated
with horizontal transfer.
Results
Product Label Information
Information declared on the product label included purpose of use (feed supplement and water
treatment) and bacterial species composition as shown in Table 1. The declared concentrations
of the individual bacterial strains varied between 106 to 1012 cfu/kg, i.e. product I contained 1.5
x 1012 B. subtilis/kg, product II contained 1 x 108 B. subtilis/B. licheniformis/B.megaterium/kg;
and product V contained between 0.2–1.2 x 106 of the seven declared Bacillus spp. (Table 1).
However, based on the serial dilutions we were only able to determine total bacterial numbers
ranging between 105-107 cfu/kg. Product I, III and IV were sold as feed supplements. The
declared purpose of use for product I was that it contained “digestive enzymes and useful bacte-
ria to improve feed digestibility in shrimp and to improve the efficiency of feed use”; product
III stated that it “provided digestive enzymes to improve feed digestibility in shrimp. Preven-
tion and treatment for white feces/stool disease. Inhibit growth of E. coli, Aeromonas. . ..
enhance immune system. Enhance survival rate, reduce stress”; and product IV stated that it
“provided digestive enzymes to improve feed digestibility in shrimp”. Products used as feed
supplements stated that 3–10 g/kg feed should be applied between 1 to 4 times per day; how-
ever, only two products described how the product should be diluted in water before mixing
with the feed and subsequent addition of a binding substance. Products I and IV were also
declared to contain phytase, amylase and amylase, protease, respectively. Products II, V, VI
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and VII used for water treatment stated on the labels that they degraded organic wastes in
water and sediment and improved water quality. Two products also stated that they absorbed
toxic gases like NH3, NO2, H2S and CH4 and one product declared that it would “change the
water color from green, dark red to a beautiful water color” as well as increasing oxygen level in
water. Product VI also declared to contain a range of different ionic metal compounds, includ-
ing CuSO4. The dose of application varied between 1 kg per 2,000–10,000 m
3 pond water
depending on the concentration of the probiotic strains in the individual product. Products for
water treatment was stated to be used in the morning every 5 to 7 days; however, it was not
declared whether products should be applied continuously during the entire production cycle.
Bacterial Species in Probiotic Products
The colonies isolated on blood agar varied in size (0.5 to 6 mm diameter), colour (frost-glass
appearance, semi-transparent, white), shape (convex, flat), surface (rough, smooth surface)
and margin (irregular margin, fine or regular margin) structures (Table 2). No visible bacterial
growth was observed for product II following heat treatment and subculture on blood agar for
isolation of Bacillus species. As Lactobacillus spp. and Pediococcus acidilactici were not identi-
fied after direct plating on blood agar, MRS agar and APT agar, the analysis of the probiotic
samples were subsequently repeated with initial enrichment in 0.9% peptone water overnight
at 30°C before subculture on the agars mentioned. However, still only Bacillus spp. was iso-
lated. Three to five colonies with identical colony morphology were selected on blood agar for
each individual probiotic product yielding a total of 125 isolates selected for subsequent identi-
fication by 16S rRNA sequence analysis (Table 2). Bacillus spp. was confirmed based on their
reactions in the initial phenotypic testing and single cell and spore formation as shown in a
phase contrast microscope after methylene blue staining. The molecular16S rRNA sequence
analysis of 119 Gram-positive and six Gram-negative bacterial specimens resulted in identifica-
tion of three genera (Bacillus, Aerococcus and Klebsiella) representing 19 species, i.e. 118 strains
of Bacillus spp., one Aerococcus urinaeequi strain and six strains of Klebsiella spp. (Table 2).
Overall, we were unable to isolate all bacterial species declared in the probiotic products.
Bacterial species identified, but not declared included several Bacillus spp., Aerococcus urinaee-
qui and Klebsiella spp. (Table 2). A total of 15 Bacillus spp. were identified compared to the 11
species declared. However, only four of the 11 declared species were isolated. Sixteen isolates
identified as Bacillus anthracis by 16S rRNA sequencing were subjected to gyrB gene sequence
analysis that confirmed 12 isolates as B. cereus. The remaining four isolates yielded incomplete
sequence data and were identified by MALDI-TOF which confirmed their identity as B. cereus
(99.9% similarity). None of the tested products declared containing B. cereus, however products
I, IV and VII did in fact contain B. cereus. Products III and V declared B. thuringiensis on the
labels, but we were not able to isolate this species. Lactobacillus spp. was declared for products
I, IV, VI and VII, but we were unable to isolate any Lactobacillus spp. Pseudomonas denitrifi-
cans was declared for product VI, but could not be recovered (Table 2). As only product IV
was found to contain Aerococcus urinaeequi and four Klebsiella spp., we obtained a new batch
from Vietnam of this product for confirmatory analysis. However, as bacterial analysis of this
new batch did not reveal any Aerococcus spp. or Klebsiella spp., we are uncertain if the finding
of these two bacterial genera in the first batch were possibly a contamination when the batch of
the probiotics was produced.
Fig 1 shows a phylogenetic analysis based on 16S rRNA gene sequences comparing Bacillus
spp. isolated from the probiotic products to type strains of the most related Bacillus species.
Seven groups were observed and five included more than one species of Bacillus reflecting their
close relationship based on the 16S rRNA gene sequence comparison. The analysis was also
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Fig 1. Neighbour joining phylogenetic tree of the 16S rRNA gene sequences representingBacillus
spp. isolated from probiotic products. Type strains of Bacillus species are labeled with accession number
and strain number. Strains with identical sequences are included in parenthesis after the strain selected as
reference. Strains with sequences shorter than 1 kb were excluded from phylogenetic analysis and their
identity only determined by similarity comparison to type strain. The scale bar represents sequence variation
considering the model for nucleotide substitution (Jukes & Cantor) and tree-shape used in the neighbour
joining analysis. * Strains are with too short sequences to compare.
doi:10.1371/journal.pone.0132338.g001
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used to evaluate the degree of deviation between the declared bacterial species on the product
and the species identified in the product.
Antimicrobial Susceptibility
A total of 65 isolates were selected for antimicrobial susceptibility testing including Bacillus
spp. (60), Klebsiella spp. (4) and Aerococcus urinaeequi (1). The antimicrobial resistance pat-
terns are shown in Table 2. In general, the Bacillus spp. strains were susceptible to a wide range
of the antimicrobials tested, e.g. 9/60 (15%) were fully susceptible to all antimicrobials tested.
Twelve (20%) isolates of Bacillus spp. were resistant to more than three antimicrobials. Resis-
tance among the Bacillus spp. was in particular seen to ampicillin (4), chloramphenicol (18),
clindamycin (23), erythromycin (10), and penicillin (11).
The three Klebsiella spp. strains were all resistant to ampicillin only whereas the Aerococcus
urinaeequi strain showed resistance to ampicillin, chloramphenicol, clindamycin, erythromy-
cin, oxacillin, penicillin and sulfamethoxazole/trimethoprim (Table 2).
Antimicrobial Resistance Genes
The following Bacillus spp. strains were selected for whole genome sequencing with the ID
number shown in brackets: B. aerius (42), B. amyloliquefaciens (8), B. cereus (26), B. lichenifor-
mis (1), B. nealsonii (91), B. tequilensis (11) (Table 2). The analysis of whole genome sequenc-
ing data revealed that a macrolide resistance gene ermD was found in B. licheniformis (1)
which showed phenotypic resistance to CHL, CLI, ERY, PEN, TET and SXT. B. tequilensis (11)
was found to contain the tetracycline resistance gene tetL and showed phenotypic resistance to
CHL, ERY, PEN, TET and SXT. The phenicol resistance gene fexA and trimethoprim resistant
genes dfrD, dfrG, dfrK were identified in Bacillus nealsonii (91) which was resistant to CHL,
CIP, ERY and SXT. Resistance genes to aminoglycosides, beta-lactams, fluoroquinolones, fos-
fomycin, fusic acid, macrolide-lincosamide-streptogramin B, rifampin, sulfonamides, tetracy-
clines, trimethoprim, glycopeptides were not found in B. amyloliquefaciens, B. aerius, and B.
nealsonii. No resistance gene of any classes of antimicrobial was identified in B. licheniformis,
B. cereus and B. tequilensis. The regions surrounding the resistance genes identified had only
similarities to the chromosome of the same species and no similarity to genes previously
shown to be involved in horizontal transfer.
Discussion
Bacterial Strain Composition
In the present study, 125 bacterial strains were isolated and identified from the selected seven
commercial probiotic products commonly used in Vietnamese shrimp culture including 118
strains of Bacillus spp., six strains of Klebsiella spp. and one Aerococcus urinaeequi strain. All
seven probiotic products contained bacterial strains that were not declared on the product
labels, i.e. a total of 11 Bacillus species identified were not declared. Further, seven Bacillus spe-
cies declared could not be isolated (Table 2). In addition, Lactobacillus spp. were declared for
products I, IV, VI and VII and Pseudomonas denitrificans in product VI, however, none of
these bacterial species were identified. Standard media and methods were used for the culture
of the different declared bacterial species which were subsequently identified by 16S rRNA and
gyrase B gene sequence analysis and MALDI-TOF.
We were occasionally able to isolate only less than five colonies of each type seen on the
individual culture media despite doing subculture from the lowest dilution of the probiotic
product (10-2) which indicates a lower concentrations of probiotic strains than declared.
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Although we find that this do not represent a major bias on the diversity of species identified it
may be that some declared species were actually present in the product but that they were not
identified, i.e. due to different species showing identical colony morphology. It should be con-
sidered to apply culture independent methods, e.g. pyro sequencing, for future determination
of bacterial strains in probiotic products.
The initial finding of Klebsiella spp. and Aerococcus urinaeequi in product IV indicates con-
tamination and inadequate quality control during manufacturing. However, these strains were
not isolated when a second batch of product IV was obtained from Vietnam and analysed. It
should be noted that we did not identify any Vibrio spp., e.g. V. parahemolyticus, which are
associated with the Early Mortality Syndrome (EMS) that currently is causing major mortalities
in cultured shrimp all over Asia [5]. As the production of various beneficial compounds and
other positive properties of probiotic bacteria are quite strain specific and such properties can
vary significantly among strains of the same bacterial species [31], the product labels should
correctly state the bacterial species included. However, further details on the actual strains, e.g.
a unique identification number, should also be provided allowing users and others to obtain
specific information about the specific strains used. None of the products analysed provided
information allowing the identification of the specific probiotic strains used.
According to the Vietnamese Ministry of Agriculture and Rural Development (MARD),
probiotic products used in aquaculture must be registered before being put on the market, e.g.
sold to shrimp farmers. The Directorate of Fisheries under MARD is responsible for the formal
approval of probiotic products for use in aquaculture. Such approval is based on performance
as documented through on-farm trials, bacterial species composition and concentration analy-
ses performed by laboratories approved by MARD, evaluation of information provided on
product labels and on-site inspection of production and storage facilities at the manufacturer
[32]. All seven probiotic products analysed in this study were on the list of approved products.
It should be noted that the total number of registered products for use in Vietnamese aquacul-
ture in 2012 was 2913, including 813 so-called veterinary drugs and 2100 chemicals, e.g. probi-
otic products, for water quality improvement and as nutritional supplements [33]. Clearly, the
approval of such a high number of registered products according to MARD requirements
would demand vast amount of resources and be highly costly. We do not know if the inade-
quate information provided about the bacterial species included and declared on the products
tested in our study may be due to inadequate testing before the products were approved or if
bacterial species composition may have been changed after product approval. Also, it seems
that a company that wants to market a new probiotic product with an identical bacterial species
composition and concentration to an already approved product does not need to document a
positive effect in on-farm trials before being put on the market. Our observations of product
labels revealed that only two products provided information about how the product should be
handled when mixing it with the feed, e.g. need to add a binding substance. Information pro-
vided on some labels were unclear and seemed to exaggerate the effectiveness of the product,
e.g. product IV was declared to increase oxygen level. Aguirre-Guzman et al. [34] proposed
that probiotics marketed for aquaculture use should specify documented effect within bacterial
antagonism, competitive exclusion of bacteria, immune stimulation, adhesion properties,
improved digestion of feed, and improved pond water quality.
Most of the microorganisms in probiotics used in aquaculture are Bacillus spp., Lactobacil-
lus spp. and yeast, although other bacterial species like Nitrosomonas spp. may also be included
[35]. We identified a total of 15 Bacillus spp. in the seven products tested and Bacillus spp.,
including B. clausii, B. licheniformis, B. cereus, B. pumilus and B. thuringiensis, are often
included in probiotic products [36] as they are reported to produce antimicrobial compounds
inhibitory to pathogens and stimulate the immune system [7]. Equally important is that
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Bacillus spp. can be kept in the spore form and therefore stored at ambient temperatures for
long periods [36]. The problems with misidentification and labelling of Bacillus spp. described
in the current study are supported by similar observation by Hoa et al. [37] who found that
Bacillus species used for oral bacteriotherapy and prophylaxis of gastroenteritis were misla-
belled as B. subtilis. Huys et al. [38] reported that more than 28% of the commercial cultures
intended for human and/or animal probiotic use were misidentified at the genus or species
level. In this study, B. anthracis was identified in products I, IV and VII based on 16S rRNA
sequence analysis. However, the 16S rRNA sequence for B. thuringiensis, B. cereus, B. anthracis,
B.mycoides, B. weihenstephanensis and B. pseudomycoides are very similar and subsequent
sequence analysis of gyrB of twelve B. anthracis strains and MALDI-TOF characterization of
another four presumptive B. anthracis strains showed that they were in fact B. cereus.
In order to evaluate the extent of deviation between declared Bacillus spp. on the product
label and species identified, the actual species of Bacillus identified were also compared by phy-
logenetic analysis. Best correspondences were found in product II and III with all isolates iden-
tified to the phylogenetic group. In product VI, isolates were allocated to one more group than
the groups that included B. subtilis and B. licheniformis labelled on the product. Worse corre-
spondence was found in products I, IV and VII that allowed the identification of Bacillus spp.
in three out of the seven phylogenetic groups besides of the group with the labelled B. subtilis.
In product V, isolates were allocated to one of the groups with the labelled species (B. licheni-
formis) but not to the group with another labelled species (B. thuringiensis) and three other
groups included isolates without labelled species.
Pheno- and Genotypic Characterization of Antimicrobial Resistance in
Probiotic Bacteria
It has been suggested that the use of live bacterial culture as dietary supplements for animal
and humans could be a neglected, but important source of antimicrobial resistance genes and
possible also pathogens [39]. Several commonly used Bacillus spp. has been shown resistant to
several antimicrobials such as chloramphenicol, tetracycline, erythromycin, lincomycin, peni-
cillin and streptomycin [37]. B. subtilis, later reclassified as B. clausii [40], used as probiotic
strain for oral bacteriotherapy was found resistant to chloramphenicol, tetracycline, rifampicin
and streptomycin [41]. Our study report for the first time on antimicrobial resistance of Bacil-
lus strains in probiotic products used in aquaculture. As expected, the different Bacillus species
showed different resistance patterns with resistance commonly seen to ampicillin, chloram-
phenicol, clindamycin, erythromycin and penicillin (Table 2). Despite the wide range of
(multi)-resistant phenotypes, the sequence analysis of the whole genome of six selected multi-
ple antimicrobial resistant Bacillus spp. only revealed resistance genes in B. licheniformis
(ermD), B. tequilensis (tetL) and B. nealsonii (fexA, dfrD, dfrG and dfrK) (Table 3). It should be
noted that resistance genes were only found for some of the phenotypic resistances shown in
the MIC testing (Tables 2 and 4). More importantly the sequence analysis did not reveal any
genetic structures, e.g. integrons and transposons, associated with horizontal gene transfer. It is
thus, not known whether the presence of some of these genes in some Bacillus strains should
be considered intrinsic. It should be noted that antibiotic producing bacteria are a natural
source of mechanism of antimicrobial resistance. In particular Bacillus spp. are known produc-
ers of many different types of antimicrobials, e.g. nicin and subtilin, that is an ability considered
a good attribute of these bacteria as probiotics [42]. As a consequence, Bacillus spp. probiotic
bacterial strains are likely to possess intrinsic mechanism of antimicrobial resistance which
may explain the mismatch between the phenotypic resistance and low number of resistance
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genes found in this study. Furthermore resistance to a specific antimicrobial may require a
complex phenotype, not depending on the expression of a single gene.
The genes found in the Bacillus spp. are encoding resistance to common drug classes
(macrolide, tetracycline, phenicol and trimethoprim) and genes associated with resistance to
cephalosporins and quinolones were not detected. Compared with the wide range of resistance
genes and mobile elements harboured by the normal aquatic bacterial flora [43], the Bacillus
spp. included in the tested probiotic products used in Vietnamese shrimp culture seem to con-
tribute with very limited types and numbers of resistance genes. It should be noted that we did
not study the presence of plasmids in Bacillus spp. which previously have been shown impor-
tant as reservoirs and vehicles for transferable resistance genes [44].
Conclusion
All seven probiotic products were approved by the Vietnamese authorities but still contained
bacterial strains that were not declared on the product labels, i.e. a total of 11 Bacillus species
identified were not declared. Further, Bacillus spp. and other bacterial species declared could
not be isolated. Although our culture-based isolation and identification may have missed a few
bacterial species present in the tested products this would represent minor bias, but future
studies may apply culture independent identification methods like pyro sequencing. Probiotic
product label information should instruct on correct use and dosage as well as allowing identi-
fication on the individual bacterial strains included rather than just informing about the bacte-
rial species. The approval of probiotic products needs to be strengthened and should include
documentation from scientific-based efficacy trials and that antibiotic resistance is not present
in probiotic strains. Overall, the Bacillus spp. showed limited phenotypic antimicrobial resis-
tance. Whole genome sequencing of selected multiple antimicrobial resistant Bacillus spp.
showed that they contained a low number of resistance genes to macrolides, tetracycline, phe-
nicol and trimethoprim, but not any genetic structures associated with horizontal gene transfer.
With reference to the recently proposed ranking of public health risks associated with antimi-
crobial resistance genes found in metagenomic studies, the genes found in our study would be
ranked as RESCon7 (lowest risks) [45]. In comparison with natural occurring bacterial species
in aquaculture environments, our study documents that the probiotic bacterial strains used in
Vietnamese shrimp culture contribute with very limited types and numbers of resistance genes.
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